|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/30 | |
| C07K 16/32 | |||
| C12N 15/13 | |||
| C12N 15/63 | |||
| A61K 39/395 | |||
| A61P 35/00 | |||
| G01N 33/53 |
| (11) | Number of the document | 3115377 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15879721.7 |
| Date of filing the European patent application | 2015-12-08 | |
| (97) | Date of publication of the European application | 2017-01-11 |
| (45) | Date of publication and mention of the grant of the patent | 2020-02-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/CN2015/096674 |
| Date | 2015-12-08 |
| (87) | Number | WO 2016/119523 |
| Date | 2016-08-04 |
| (30) | Number | Date | Country code |
| 201510051280 | 2015-01-30 | CN |
| (72) |
ZHOU, Qing, CN
SHU, Mengjun, CN
HE, Zhuzi, CN
LIN, Jun, CN
|
| (73) |
Genor Biopharma Co., Ltd,
1690 Zhangheng Road Building 3 Floor 1-4 Zhangjiang Pudong, Shanghai 201203,
CN
|
| (54) | MUTANT ANTIBODY OF FULL HUMAN HER2 ANTIBODY, CODING GENE AND USE THEREOF |
| MUTANT ANTIBODY OF FULL HUMAN HER2 ANTIBODY, CODING GENE AND USE THEREOF |